Knee osteoarthritis is a complex disease that affects the whole joint, including bone, cartilage, ligaments and muscles. Osteoarthritis is a common cause of pain and movement difficulty, affecting 8.3 ...

The nation's health secretary reportedly plans to remove restrictions on selling peptide injections — making them available to more people. Dr. Abby Waldman from Mass. General Brigham tells you what ...

Clinical data from a phase 3 trial show Ponlimsi has comparable safety and efficacy to Prolia in women with postmenopausal osteoporosis. The Food and Drug Administration (FDA) has approved Ponlimsi ™ ...

The Food and Drug Administration has approved Teva's Prolia biosimilar, and the agency is reviewing Teva's Xolair biosimilar application. “The FDA approval of Ponlimsi is a significant milestone that ...

On March 30, 2026, Teva announced that the FDA and the European Medicines Agency (EMA) accepted regulatory submissions for its proposed biosimilar to Xolair ® (omalizumab), TEV-45779. The submissions ...

Novartis has penned a $2 billion deal for a biotech whose next-gen anti-immunoglobulin E (IgE) program could offer a worthy successor to Xolair. Excellergy has been snapped up by the Swiss pharma only ...

If you could inject yourself with a substance that purports to make you tanner, fitter and healthier, would you? Many people are saying “yes.” Online, social media influencers tout vials of substances ...

Our Verdict: DirectMeds offers one of the most accessible NAD+ injection programs in the telehealth space. With LegitScript certification, 180,000+ customers, a 4.6-star Trustpilot rating, and ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The lawsuit alleges the imported ...